Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Raw Materials: 2017-2023

Historic Raw Materials for China Pharma Holdings (CPHI) over the last 7 years, with Dec 2023 value amounting to $1.8 million.

  • China Pharma Holdings' Raw Materials fell 53.69% to $869,820 in Q3 2024 from the same period last year, while for Sep 2024 it was $869,820, marking a year-over-year decrease of 53.69%. This contributed to the annual value of $1.8 million for FY2023, which is 0.52% up from last year.
  • China Pharma Holdings' Raw Materials amounted to $1.8 million in FY2023, which was up 0.52% from $1.8 million recorded in FY2022.
  • In the past 5 years, China Pharma Holdings' Raw Materials registered a high of $2.1 million during FY2019, and its lowest value of $1.8 million during FY2021.
  • Over the past 3 years, China Pharma Holdings' median Raw Materials value was $1.8 million (recorded in 2022), while the average stood at $1.8 million.
  • Per our database at Business Quant, China Pharma Holdings' Raw Materials crashed by 32.87% in 2019 and then rose by 0.52% in 2023.
  • Yearly analysis of 5 years shows China Pharma Holdings' Raw Materials stood at $2.1 million in 2019, then dropped by 1.53% to $2.1 million in 2020, then decreased by 11.63% to $1.8 million in 2021, then remained steady at $1.8 million in 2022, then increased by 0.52% to $1.8 million in 2023.